<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0000833'>Impaired glucose tolerance</z:hpo> (IGT) is an insulin-resistant state and a risk factor for Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The relative roles of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and insulin deficiency in IGT have been disputed </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In 40 IGT subjects and 63 sex-, age-, and weight-matched controls with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT), we measured (i) indices of insulin sensitivity of fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> production (by tracer <z:chebi fb="105" ids="17234">glucose</z:chebi>) and <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal (M value on a 240 pmol x min(-1) x m(-2) insulin clamp) and (ii) indices of beta-cell function (<z:chebi fb="105" ids="17234">glucose</z:chebi> sensitivity, rate sensitivity, and potentiation) derived from model analysis (Am J Physiol 283:E1159-E1166, 2002) of the insulin secretory response (by C-<z:chebi fb="7" ids="16670">peptide</z:chebi> deconvolution) to oral <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In comparison with NGT, IGT were modestly insulin resistant (M=29+/-2 vs 35+/-2 micromol x min(-1) x kg(FFM)(-1), p=0.01); insulin sensitivity of <z:chebi fb="105" ids="17234">glucose</z:chebi> production also was reduced, in approximate proportion to M </plain></SENT>
<SENT sid="4" pm="."><plain>Despite higher baseline insulin secretion rates, IGT was characterized by a 50% reduction in <z:chebi fb="105" ids="17234">glucose</z:chebi> sensitivity [53 (36) vs 102 (123) pmol x min(-1) x m(-2) x mM(-1), median (interquartile range), p=0.001] and impaired potentiation [1.6 (0.8) vs 2.0 (1.5) units, p&lt;0.04] of insulin release, whereas rate sensitivity [1.15 (1.15) vs 1.38 (1.28) nmol x m(-2) x mM(-1)] was not significantly reduced </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> sensitivity made the single largest contribution (approximately 50%) to the observed variability of <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION/INTERPRETATION: In IGT the defect in <z:chebi fb="105" ids="17234">glucose</z:chebi> sensitivity of insulin release quantitatively predominates over <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in the genesis of the reduced tolerance to oral <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
</text></document>